Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
BioHarvest Sciences Inc. has successfully converted CAD $5,675,059.91 of convertible debt into 22,826,132 common shares, issuing additional early exercise warrants as a part of the deal. This strategic financial move is part of the company’s innovative approach using their patented Botanical Synthesis technology to develop plant-based molecules for health and wellness products. Investors may see this as a positive step towards the company’s stability and growth in the biotech sector.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
